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It is important for public health professionals to understand the effects of vaccine introduction 
and compare different types of vaccinations. This study will focus on understanding the pre and 
post vaccination effects of two different infectious diseases: pneumonia and gastrointestinal 
disorders. One of approaches of getting the accurate estimate of vaccine impact is by comparing 
rates or trends of the targeted disease in the years after introduction with rates of trend in the 
year before introduction using a time-series analysis. Specifically, in this study, the synthetic 
controls method implements an approach to estimating the causal effect of a designed 
intervention on a time series. With this new approach, potential comparison time series are 
combined into a composite and are used to generate a counterfactual estimate, which can be 
compared with the time series of interest, which are effect of vaccines on pneumonia or 
gastrointestinal disorders after the intervention. After conducting time series analysis on five 
different regions of Brazil and in national level, this study finds that the introduction of 
pneumonia vaccine in five regions of Brazil results in a significant increasing in case prevented 
and decreasing in observed cases compared to synthetic control estimated cases. However, unlike 
pneumonia vaccine, introduction of gastrointestinal disorder vaccine is not significantly effective 
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Vaccination, as an epidemiological intervention, is important to keep infectious diseases from 
spreading. After vaccination, public health practitioners will monitor the infectious disease rate in 
order to make sure that the vaccine is effective and beneficial to the community. One of 
approaches of getting the accurate estimate of vaccine impact is by comparing rates or trends of 
the targeted disease in the years after introduction with rates of trend in the year before 
introduction using a time-series analysis.[1]  
Before the introduction of vaccination in the United States, rotavirus caused about 2.7 million 
cases of severe gastroenteritis in children, almost 60,000 hospitalizations, and around 37 deaths 
per year.[2] At the same time, also in the United States, pneumonia accounts for 3–18% of all 
childhood hospital admissions.[1] For people aged 65 years or older, nearly one million episodes 
of community-acquired pneumonia occur every year, with 40% resulting in admission.[3] In the 
developing countries, pneumonia still remains a leading cause of death across different age 
groups.[4] Introduction of a new vaccine is expected to provide direct protection for suspected 
population by immunizing individuals. The suspected population could also be indirectly 
protected from herd immunity because of the increasing number of vaccinated individuals. 
Therefore, the spreading of the infectious disease could be controlled and the admission number 
of hospitalization caused by infection would be averted significantly. In our study, both effects of 
rotavirus and pneumococcal vaccines are measured based on the hospitalization data.  
Instead of focusing on the seasonal changes of infectious disease, this study is controlled for 
seasonality while estimating the total effect (direct & indirect) of these vaccines across different 
age groups based on the data of hospitalization. Data were collected at the national and regional 
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level of Brazil with the outcomes of either pneumonia or gastrointestinal disorders including both 
pre and post-vaccination. Comparison of rotavirus vaccine and pneumonia vaccine effects on 
gastrointestinal disorders and pneumonia will be conducted to generate evidence on public 
health impact. The aversion of hospitalization admission is used as the end point to estimate the 
effect of vaccines. 
In this study, the synthetic controls method, which was originally developed and named as 
“Casual impact” in R package, which implements an approach to estimating the causal effect of a 
designed intervention on a time series. This method is based on the assumption that there is a 
set of control time series that were themselves not affected by the intervention, which in our 
study is that control infectious diseases were not affected by the introduced vaccines. With this 
new approach, potential comparison time series are combined into a composite and are used to 
generate a counterfactual estimate, which can be compared with the time series of interest, 
which are effect of vaccines on pneumonia or gastrointestinal disorders after the intervention.[1] 
 
Methods 
Sources of Data 
Hospitalization data were obtained from national and regional level data of Brazil across different 
age groups from the Hospital Information System administrative database of the National Unified 
Health System (SIH-SUS). We expect to include pre-vaccination and post-vaccination 
hospitalization data. Targeted individuals were diarrhea-related hospitalization and pneumonia 
admission, therefore only these two types of data were needed to be collected and analyzed. 
More specifically, based on the International Classification of Diseases (ICD-10), J12-J18 is the 
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targeted code for influenza and pneumonia and A00-A09 is the targeted code for intestinal 
infectious disease from the hospitalization data.  
 
Definition of pneumonia hospitalization 
In this study the following ICD-10 codes are used: J12, viral pneumonia; J13, Streptococcus 
pneumoniaecaused pneumonia; J14, Haemophilus influenzaecaused pneumonia; J15, bacterial 
pneumonia not otherwise specified; J16, other infectious organism not elsewhere classified; J17, 
pneumonia in diseases classified elsewhere; and J18, unspecified organism.[5] 
 
Definition of intestinal infectious disease hospitalization 
In this study the following ICD-10 codes are used: A00, Cholera; A01, Typhoid and paratyphoid 
fevers; A02, other salmonella infections; A03, Shingellosis; A04, Other bacterial intestinal 
infections; A05, Other bacterial foodborne intoxications, not elsewhere classified; A06, Amebiasis; 
A07, Other protozoal intestinal diseases; A08, Viral and other specified intestinal infections; A09, 
Infections gastroenteritis and colitis, unspecified.[5] 
 
Study Population 
The present investigation included children aged under two years old living in Brazil, hospitalized 
due to all causes from January 2010 to December 2013, in all five different regions of Brazil: 






Table and definition for controls of synthetic control estimation model 
ICD-10 Code for Control Definition 
A17 Tuberculosis of nervous system 
A18 Tuberculosis of other organs 
A19 Miliary tuberculosis 
A39 Meningococcal infection 
A41 Other sepsis 
B20_24 Human immunodeficiency virus [HIV] disease 
B34 Viral infection of unspecified site 
B96 Other bacterial agents as the cause of diseases 
classified elsewhere 
B97 Viral agents as the cause of diseases classified 
elsewhere 
B99 Other and unspecified infectious diseases 
C00_D48 Neoplasms 
D50_89 Diseases of the blood and blood-forming 
organs and certain disorders involving the 
immune mechanism 
E00_99 Endocrine, nutritional and metabolic diseases 
I00_99 Diseases of the circulatory system 
J20_J22 Other acute lower respiratory infections 
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K00_99 Diseases of the digestive system 
L00_99 Diseases of the skin and subcutaneous tissue 
M00_99 Diseases of the musculoskeletal system and 
connective tissue 
N00_99 Diseases of the genitourinary system 
P00_99 Certain conditions originating in the perinatal 
period 
Q00_99 Congenital malformations, deformations and 
chromosomal abnormalities 
S00_T99 Injury, poisoning and certain other 
consequences of external causes 
V00_Y99 External causes of morbidity 
Z00_99 Factors influencing health status and contact 
with health services 
 
Significance 
Synthetic control model is used to detect and adjust for unmeasured bias and confounding in the 
evaluation of vaccine programs.[1] Using data from regional level of Brazil in North, Northeast, 
Center-West, Southeast and South, the synthetic control model can evaluate the changing of 
hospitalization due to all-cause pneumonia and gastrointestinal disorders with the introduction 
of corresponding vaccines. Comparing to other linear regression and time series model, this 
method is likely to increase the accuracy and effectively adjust for unexplained trends in the 
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hospitalization data from these five regions of Brazil. 
 
Statistical analysis 
Hospitalization data was analyzed through synthetic control method in order to adjust for 
seasonal changes and unexpected trends. Because many unexpected factors aside from targeted 
vaccination could influence the disease rate, it is necessary to use control diseases to adjust for 
unrelated trends. First of all, linear regression model will be used to fit the data from pre-vaccine 
hospitalization for establishing a relationship between control and targeted diseases. After that, 
post-vaccine data for control disease will be plugged in to predict the estimated targeted disease 
value. Finally, the estimated targeted disease hospitalization data will be compared to observed 
hospitalization data to obtain the difference. Analyzed results will yield hospitalization incidence 
changing in all states of Brazil in different age groups.  
 
Key assumptions:  
1. None of the control diseases are influenced by these two vaccines. 




We expected to observe changes in incidence from time series analysis generated results in 
certain age groups. It is possible that different age groups present different scenarios in the time 
series. The differences in hospitalization decline after introduction of vaccines between states in 
10 
 
Brazil are likely to be detected from the evidence generated by time series analysis. More 
importantly, the declination of hospitalization for gastrointestinal disorders and pneumonia could 
be different due to underlying factors like geographic locations, suspected populations, 
transmission rate and more.  
 
Comparison of incidence counts in regional and national level of Brazil: 
This is the graph to illustrate the different incidence counts of both infectious diseases in 
different regions of Brazil and in two different age groups under two years old. Specifically, the 
red triangles represent the incidences of gastrointestinal disorders while the blue dots represent 
the incidences of pneumonia. The number on the x-axis represents the region number of Brazil, 
at the same time A represents the national level incidences of both diseases. According to this 
graph, region one incidence counts of both infectious diseases are close to each other with 
amount around 50000; region two the incidences of gastrointestinal disorders, which are about 
120000, are higher than the incidences of pneumonia, which are about 100000; region three the 
incidences of pneumonia are higher than the incidences of gastrointestinal disorders in both age 
groups, with larger difference in less than 12 months age group; region four overall the 
incidences of pneumonia are higher than the incidences of gastrointestinal disorders in both age 
groups as well; region five both incidences of two diseases have similar lower counts than other 
regions of Brazil. In the national level, the incidences of both diseases are higher in less than 12 
months age groups. Additionally, incidences of pneumonia are higher than gastrointestinal 




Comparison of Adjusted number of cases in regional and national level of Brazil: 
This graph is adjusted for the overall hospitalization data of Brazil for pneumonia and 
gastrointestinal disorder incidences. Similarly, the red triangles represent the incidences of 
gastrointestinal disorders while the blue dots represent the incidences of pneumonia. The 
dashed gray line separated the overall graph into two parts: the right part represents the 
adjusted number of cases for 12-23 months age group, the left part represents the adjusted 
number of cases for under 12 months age group. It is obvious to find out that under 12 months 
age group has lower adjusted number of cases, which is below 1.0, in all regions of Brazil 
compared to 12-23 months age group. At the same time, the adjusted number of cases of 
pneumonia is lower compared to the adjusted number of cases of gastrointestinal disorder in two 
different age groups. The only exceptions are on the left side of the graph, where region one and 
region two with 12-23 months age group have higher pneumonia adjusted number of cases 
compared to gastrointestinal disorder. Therefore, before the introduction of vaccination of both 






Plot of Rate ratios, with size proportional to cross validation weights: 
The dash line in this graph is rate ratio equal to one, which means there is no difference of 
individuals getting infected post-vaccination compared to pre-vaccination. The points below the 
dash line means that the overall rate ratio is lower than one, which means the number of 







By checking the synthetic controls model for effect of vaccines on pneumonia, the study shows 
that the rate ratio for all the age groups in five regions of Brazil is lower than one. At the same 
time, most of the age groups with four different analysis methods show similar rate ratio lower 
than one.  
 
A00_A09: 
By checking the synthetic controls model for effect of vaccines on gastrointestinal disorders, the 
study shows that the rate ratios for all the age groups in five regions of Brazil are distributed 
either above the dash line or below it. Most of the synthetic controls rate ratios are close to one, 
which is no different between post-vaccination and pre-vaccination. At the same time, most of 






Plot Observed vs expected yearly time series: 
In these groups, horizontal black lines represent the expected number of cases derived from 
synthetic controls estimate, while the black dots are real-life observed number of cases. The gray 
area contains the black line are the 95% confidence interval for expected number of cases. The 




The first region for age group under 2 years old has lower number of cases for observed number 
of cases compared to expected number of cases derived from synthetic controls estimate after 
2010. The observed number of cases for age group 12 month to 23 month is out of the 95% 
confidence interval of expected number of cases. However, the observed number of cases age 
group under 12 months is within the 95% confidence interval of expected number of cases.  
Similarly for region two, region three and region five, age group under 2 years old has lower 
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number of cases for observed number of cases compared to the expected number of cases 
derived from synthetic controls estimate after 2010. Additionally, both observed numbers of 
cases for age groups are out of the 95% confidence interval of expected number of cases. 
At last, region four for age group under 2 years old has lower number of cases for observed 
number of cases compared to expected number of cases derived from synthetic controls 
estimate after 2010. The observed number of cases for age under 12 month is out of the 95% 
confidence interval of expected number of cases. However, the observed number of cases age 
group between 12 month and 23 month is within the 95% confidence interval of expected 











It is obvious that the confidence interval is much wider after year 2010 for the expected number 
of cases generated from synthetic control estimated. In general, the first region for age group 
under 2 years old has lower number of cases for observed number of cases compared to 
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expected number of cases derived from synthetic controls estimate after 2010. Both of the 
observed number of cases for age group under 2 years old is out of the 95% confidence interval 
of expected number of cases.  
However, for all the other regions, the differences are not so obvious. For region two, three, four 
and five, some of the observed numbers of cases are above the expected number of cases 
generated from synthetic control estimated. Most of the observed numbers of cases are in the 95% 














National level cumulative cases prevented for both vaccines: 
J12_J18: 
From these two graphs, the cumulative sum of incidence prevented for pneumonia increases 
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significantly after the introduction of vaccine after 2010, which approximately reaching 60000 for 
age group between 12 month and 23 month, and reaching over 90000 for age group below 12 
month. The 95% confidence interval for both age groups are above the line of zero cumulative 
sums prevented. At the same time, the 95% confidence interval for the cumulative sum is wider 




From these two graphs, the cumulative sum of incidence prevented for gastrointestinal disorders 
is not increased significantly after the introduction of vaccine after 2010 for age group between 
12 month and 23month because the 95% confidence interval includes the zero cumulative sums 
prevented in this age group. While for the age group under 12 month, the cumulative sum of 
incidence prevented increased significantly with 95% confidence interval above the zero line for 
cumulative sum. At the same time, the 95% confidence interval for the cumulative sum is wider 







Overall, the incidence counts of pneumonia are higher than the incidence counts of 
gastrointestinal disorders in national and regional level. However, the regional differences were 
observed as well. The only exception for the incidence counts of gastrointestinal disorders higher 
than the incidence counts of pneumonia is region two. The incidence counts of pneumonia are 
also higher in age group less than 12 months compared to age group between 12 month and 23 
month, while the incidence counts of gastrointestinal disorders are similar for both age groups in 
each region and in national level. In general, the prevalence of pneumonia is higher than 
gastrointestinal disorders in younger patient population according to the hospitalization data. 
Based on this knowledge, public health professionals and hospitals should prepare more vaccines 
for pneumonia then vaccines for gastrointestinal disorders for younger patients in Brazil.  
At the same time, there is no significant different between post-vaccination and pre-vaccination 
for gastrointestinal disorders, which there is obvious lower rate ratio difference between 
post-vaccination and pre-vaccination for pneumonia. The study shows that there is a significant 
difference between the expected number of cases generated from synthetic control estimated 
and the observed number of cases after the introduction of vaccines of pneumonia in all five 
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different regions in Brazil. At the same time, the observed number of cases is generally 
decreasing each year after the introduction of vaccine in 2010. Between two different age groups, 
both show similar decreasing patterns after the introduction of vaccines. Unlikely vaccines of 
pneumonia, the introduction of gastrointestinal disorders vaccines effect are only obvious in 
region one for both age group. There is not a significant difference between the expected 
number of cases generated from synthetic control estimated and the observed number of cases 
for region two, three, four and five. Age group of between 12 month and 23 month even shows 
an increased number of observed cases compared to expected number of cases generated from 
the analysis. At the same time, the confidence interval after the introduction of vaccines in 2010 
is wider for gastrointestinal disorders according to the analysis.  
There is a significant increasing of the case prevented after the introduction of vaccine for 
pneumonia for both age groups, while the cases prevented increase only shows in the age group 
under 12 months after the introduction of vaccine for gastrointestinal disorders. Therefore, it is 
obvious that the vaccination process greatly helps the prevention of pneumonia infections for 
patients under two years old, and the effect of this vaccine is keeping increasing by observing the 
steady increasing cases prevented over these years. In general, the vaccine for pneumonia is 
significantly effective and could keep benefiting this population in the Brazil for the upcoming 
future. However, unlike vaccine for pneumonia, the vaccine for gastrointestinal disorders shows 
significant differences for two different age groups. It is hard to determine whether the vaccine is 
effective for age group 12-23 months and under 12 months by considering confidence interval. It 
is likely that the vaccination is more effective among older patients because patients under 12 
months don’t expose to too many types of foods, which could potentially cause the 
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gastrointestinal disorders.  
 
Limitations: 
This study only concerns the younger age group, which are under 2-year-old patients with 
hospitalization data of pneumonia and gastrointestinal disorders. It is possible that other age 
groups with older patients could show different synthetic control results in different regions of 
Brazil. Individuals with mature immune system could become less susceptible to infectious 
diseases like pneumonia and gastrointestinal disorders. Because this study is conducted in a 
regional and national level instead of state specific level, the geography characteristic is overall 
more generalized and over-simplified. Geographic difference is an important factor that 
influencing the prevalence and spreading of infectious diseases. Conditions like number of 
hospitals, environment hygiene, social economic status, public health facilities and etc. could 
contribute and impact the effect after the introduction of vaccine in different regions of Brazil. In 
general, geographic differentiation is too general for this study. 
 
Conclusion 
The introduction of pneumonia vaccine in five regions of Brazil results in a significant increasing 
in case prevented and decreasing in observed cases compared to synthetic control estimated 
cases. However, unlike pneumonia vaccine, introduction of gastrointestinal disorder vaccine is 






 Define the scope and worldwide impact of infectious diseases. 
 Describe the processes that drive transmission and maintenance of infectious agents. 
 Describe the epidemiology of the major infectious diseases worldwide as well as risk 
exposures and behaviors as these relate to transmission. 
 Explain the interrelationship between the environment and the emergence and 
maintenance of infectious diseases in populations. 
 Describe and critically evaluate approaches for the prevention and control of infectious 
diseases and define the key issues to their effective use. 
 Apply principles and concepts obtained through coursework to design and implement 
studies on the etiology, detection, prevention or control of infectious diseases in the 
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